Pacific Biosciences of California Inc - ESG Rating & Company Profile powered by AI
The Sustainability assessment for Pacific Biosciences of California Inc represents the company's reporting of the United Nations Sustainable Development Goals. If you work at Pacific Biosciences of California Inc and you would like to use your Sustainability rating, please get in touch. This dashboard includes a Q&A section on Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Pacific Biosciences of California Inc | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Pacific Biosciences of California Inc have an accelerator or VC vehicle to help deliver innovation?
Does Pacific Biosciences of California Inc disclose current and historical energy intensity?
Does Pacific Biosciences of California Inc report the average age of the workforce?
Does Pacific Biosciences of California Inc reference operational or capital allocation in relation to climate change?
Does Pacific Biosciences of California Inc disclose its ethnicity pay gap?
Does Pacific Biosciences of California Inc disclose cybersecurity risks?
Does Pacific Biosciences of California Inc offer flexible work?
Does Pacific Biosciences of California Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Pacific Biosciences of California Inc disclose the number of employees in R&D functions?
Does Pacific Biosciences of California Inc conduct supply chain audits?
Does Pacific Biosciences of California Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Pacific Biosciences of California Inc conduct 360 degree staff reviews?
Does Pacific Biosciences of California Inc disclose the individual responsible for D&I?
Does Pacific Biosciences of California Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Pacific Biosciences of California Inc disclose current and / or historical scope 2 emissions?
Does Pacific Biosciences of California Inc disclose water use targets?
Does Pacific Biosciences of California Inc have careers partnerships with academic institutions?
Did Pacific Biosciences of California Inc have a product recall in the last two years?
Does Pacific Biosciences of California Inc disclose incidents of discrimination?
Does Pacific Biosciences of California Inc allow for Work Councils/Collective Agreements to be formed?
Has Pacific Biosciences of California Inc issued a profit warning in the past 24 months?
Does Pacific Biosciences of California Inc disclose parental leave metrics?
Does Pacific Biosciences of California Inc disclose climate scenario or pathway analysis?
Does Pacific Biosciences of California Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Pacific Biosciences of California Inc disclose the pay ratio of women to men?
Does Pacific Biosciences of California Inc support suppliers with sustainability related research and development?
Does Pacific Biosciences of California Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Pacific Biosciences of California Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Pacific Biosciences of California Inc involved in embryonic stem cell research?
Does Pacific Biosciences of California Inc disclose GHG and Air Emissions intensity?
Does Pacific Biosciences of California Inc disclose its waste policy?
Does Pacific Biosciences of California Inc report according to TCFD requirements?
Does Pacific Biosciences of California Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Pacific Biosciences of California Inc disclose energy use targets?
Does Pacific Biosciences of California Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Pacific Biosciences of California Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Pacific Biosciences of California Inc
These potential risks are based on the size, segment and geographies of the company.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform; and a research collaboration with Rady Children's Institute for Genomic Medicine for whole genome sequencing platform. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.